DXtrade FX/ CFD Platform Integrated with Your Bourse for Turnkey Liquidity

Pressat

Published

Wednesday 7 December, 2022DXtrade brokers received access to 30+ major banks and Tier 2 liquidity providers with Your Bourse.

London —Devexperts announced today that it has partnered with Your Bourse to expand the range of technology providers it offers as a turnkey integration with DXtrade, the Devexperts’ flagship trading platform for FX, CFD, and cryptocurrency brokers.

This partnership allows DXtrade brokers to leverage integration with Your Bourse and connect to industry-leading liquidity providers. This includes access to 30+ major banks and Tier 2 liquidity providers once brokers choose Your Bourse.

Your Bourse is a technology provider that allows brokers to run their central order book based on the matching engine technology, as well as to aggregate liquidity into unique streams, be it Forex, CFDs, Crypto, or any other asset class. In addition, brokers can set up unlimited liquidity pools as well as pricing rules and order routing parameters most suitable for their order flow to deliver tight spreads and bespoke execution to their traders.

Your Bourse is written in C++ and is an ultra-low latency platform hosted in Equinix data centers (LD4, LD5, NY4, NY5, CH1, HK1, TY3, FR2), CME Aurora (DC3), Interxion London (Lon1), Singapore (SGX). Integration with Your Bourse also guarantees advanced A/B-book routing and dynamic routing based on margins that a broker uses with each liquidity provider. Most importantly, Your Bourse offers brokers an opportunity to also distribute their own liquidity to other market participants.

“We see our partnership between Devexperts and Your Bourse as being strategic because of their competitive offering and the growing demand for their services by DXtrade’s customers. As DXtrade becomes a platform of choice by established brokers, the Your Bourse offering makes it easier for those who have more than one platform to manage the execution side of their business in one place”, said Jon Light, Head of OTC Product at Devexperts.

“DXtrade is an outstanding product being selected by various of our clients to expand on their platform offering due to the customizations DXtrade offers. We are delighted to work with such a professional team as Devexperts and we hope that this partnership will allow us to deliver a great product together”, said Elina Pedersen, Chief Revenue Officer of Your Bourse.

The DXtrade platform is constantly growing. Its recent addition of spread bets now caters to UK brokers looking to diversify and expand their audience.

About Devexperts

Devexperts has been developing software for the capital markets since 2002. The company’s core business expertise is in trading platforms, namely DXtrade XT for listed securities and derivatives, DXtrade CFD for OTC asset classes, and DXtrade Crypto for cryptocurrencies. The range of software also includes DXmatch for exchange solutions, dxFeed for market data, and many more. Visit our website: https://devexperts.com/

Follow us on: Twitter and LinkedIn

Contact Devexperts:

Elena Gorbacheva, PR manager,

pr@devexperts.com

+49(8926)2077300 ext. 7010

About Your Bourse

Your Bourse is a London-based company founded by Andrey Vedikhin. Your Bourse provides a Platform-as-a-Service solution for FX, CFD and crypto liquidity management, data analytics, reporting and risk management solutions to the retail brokerage and institutional marketplace. The flexible and competitive pricing policy and bespoke packages allow companies of all sizes and capacity to safely benefit from Your Bourse tools. Brokers also get access to hosting services in Equinix data centers and lightning-fast execution.

For further information on Your Bourse or to schedule a demo, please visit: https://www.yourbourse.com/

For media information, please contact:

Name: George Jubran, Your Bourse

Email: george@yourbourse.com

Telephone Number: +44 7769 358193

Cyprus Office: 2nd Floor, Thalia 3, Office Number 212, Limassol 3011, Cyprus

Distributed by https://pressat.co.uk/

Full Article